Sort
48,018 grants matching “immunotherapy”
In Vivo Hematopoietic Stem Cell Gene Therapy of Beta-Thalassemia and Sickle Cell Disease
$644,784Andre Michael Lieber · University Of Washington · R01 · FY2024 · HL
Neoadjuvant immunoradiotherapy for HPV mediated oropharynx cancer
$644,774Joseph A Califano · University Of California, San Diego · R01 · FY2023 · CA
Redox Mechanism Process of Angiogenesis and Wound Healing
$644,771David Wink · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma
$644,765James Louis Rubenstein · University Of California, San Francisco · R01 · FY2020 · CA
Defining the Mechanistic Basis of Bacterial Androgen Production in Dampening Anti-Tumor Immunity and Promoting Resistance to Androgen Receptor Axis-Targeted Therapies for Metastatic Prostate Cancer
$644,763Karen Sandell Sfanos · Johns Hopkins University · R01 · FY2025 · CA
Targeting posttranslational modifications of CD73 in TNBCs
$644,746Yong Wan · Emory University · R01 · FY2025 · CA
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer
$644,727Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2018 · CA
Engineering Knotted Peptide Therapeutics for Pediatric Brain Tumor Patients
$644,689James M Olson · Seattle Children'S Hospital · R01 · FY2022 · CA
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$644,646Joshua Aiden Hill · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
Developmental Funds
$644,639Thomas P Loughran · University Of Virginia · P30 · FY2019 · CA
Elucidate how dendritic cells affect T cells' function in the TME of non-small cell lung cancer
$644,606Chen Zhao · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Multiplex food allergy diagnostic based on IgE immunologic markers
$644,600David Seftel · Enable Biosciences, Inc. · R44 · FY2021 · AI
Developing Safe and Effective GD2-CAR T Cell Therapy for Diffuse Midline Gliomas
$644,430Crystal Mackall · Stanford University · R01 · FY2022 · CA
Impact of mutation burden on cancer growth and the immune landscape
$644,404Shridar Ganesan · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
Impact of mutation burden on cancer growth and the immune landscape
$644,401Shridar Ganesan · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
Single Cell Methods for Bioeffector Discovery and Analysis
$644,351Brian O Bachmann · Vanderbilt University · R01 · FY2025 · CA
Brain Tumors - Immunological and Biological Studies
$644,338Duke University · R37 · FY2005 · CA
Validation of a novel 3D culture platform for TNBC treatment selection
$644,226Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2022 · CA
Administrative Core
$644,149Jonathan P Schneck · Johns Hopkins University · P41 · FY2024 · EB
Protective adaptive immune mechanisms after cardiac arrest
$644,111Sergey Ryzhov · Mainehealth · R01 · FY2024 · HL
Protective adaptive immune mechanisms after cardiac arrest
$644,111Sergey Ryzhov · Mainehealth · R01 · FY2025 · HL
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
$644,078Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Amyloid Beta CAR Macrophages: a cell engineering strategy to clear pathogenic proteins
$644,077Saar Gill · University Of Pennsylvania · R01 · FY2025 · NS
CORE C Technology Implementation/Development and Correlative Sciences
$644,007Friederike Herbst-Nowrouzi · University Of Pennsylvania · P01 · FY2023 · CA
MECHANISMS OF CHRONIC HEPATITIS B INFECTION
$643,993Vaccine Research Institute Of San Diego · R01 · FY2002 · AI